Zoetis reported a strong third quarter in 2020, with revenue reaching $1.8 billion, a 13% increase compared to the previous year. Net income also saw an 11% increase, amounting to $479 million, or $1.00 per diluted share. The company's companion animal business was a key driver of growth, and livestock also contributed positively, especially in the U.S. cattle and China's swine markets. Due to the strong performance, Zoetis is increasing its full-year guidance for 2020.
Revenue reached $1.8 billion, a 13% increase year-over-year.
Net income increased by 11% to $479 million, or $1.00 per diluted share.
Adjusted net income was $524 million, or $1.10 per diluted share.
Companion animal products, particularly Simparica Trio and key dermatology products, drove sales growth.
Zoetis is increasing its full year 2020 guidance, including revenue between $6.550 billion and $6.625 billion, reported diluted EPS between $3.38 and $3.45, adjusted diluted EPS between $3.76 and $3.81.
Visualization of income flow from segment revenue to net income